261 related articles for article (PubMed ID: 19379515)
1. CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.
Antognelli C; Del Buono C; Ludovini V; Gori S; Talesa VN; Crinò L; Barberini F; Rulli A
BMC Cancer; 2009 Apr; 9():115. PubMed ID: 19379515
[TBL] [Abstract][Full Text] [Related]
2. Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer.
Antognelli C; Mearini L; Talesa VN; Giannantoni A; Mearini E
Prostate; 2005 May; 63(3):240-51. PubMed ID: 15538743
[TBL] [Abstract][Full Text] [Related]
3. Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.
Hussein YM; Gharib AF; Etewa RL; ElSawy WH
Mol Cell Biochem; 2011 May; 351(1-2):117-23. PubMed ID: 21229382
[TBL] [Abstract][Full Text] [Related]
4. GLYOXALASE I A111E, PARAOXONASE 1 Q192R AND L55M POLYMORPHISMS IN ITALIAN PATIENTS WITH SPORADIC CEREBRAL CAVERNOUS MALFORMATIONS: A PILOT STUDY.
Rinaldi C; Bramanti P; Famà A; Scimone C; Donato L; Antognelli C; Alafaci C; Tomasello F; D'Angelo R; Sidoti A
J Biol Regul Homeost Agents; 2015; 29(2):493-500. PubMed ID: 26122242
[TBL] [Abstract][Full Text] [Related]
5. Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.
Ahmed NS; Shafik NM; Elraheem OA; Abou-Elnoeman SE
Asian Pac J Cancer Prev; 2015; 16(2):803-9. PubMed ID: 25684529
[TBL] [Abstract][Full Text] [Related]
6. Steroid metabolism gene polymorphisms and their implications on breast and ovarian cancer prognosis.
Dos Santos EVW; Alves LNR; Louro ID
Genet Mol Res; 2017 Jul; 16(3):. PubMed ID: 28692125
[TBL] [Abstract][Full Text] [Related]
7. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
[TBL] [Abstract][Full Text] [Related]
8. Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?
Sidoti A; Antognelli C; Rinaldi C; D'Angelo R; Dattola V; Girlanda P; Talesa V; Amato A
Mult Scler; 2007 May; 13(4):446-53. PubMed ID: 17463067
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
10. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
[TBL] [Abstract][Full Text] [Related]
11. Glyoxalase 1-419C>A variant is associated with oxidative stress: implications in prostate cancer progression.
Antognelli C; Mezzasoma L; Mearini E; Talesa VN
PLoS One; 2013; 8(9):e74014. PubMed ID: 24040147
[TBL] [Abstract][Full Text] [Related]
12. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
[TBL] [Abstract][Full Text] [Related]
13. Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms.
Haj Mouhamed D; Ezzaher A; Mechri A; Neffati F; Omezzine A; Bouslama A; Gaha L; Douki W; Najjar MF
Environ Health Prev Med; 2012 Jul; 17(4):316-21. PubMed ID: 22205545
[TBL] [Abstract][Full Text] [Related]
14. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis.
Liu C; Liu L
Tumour Biol; 2011 Dec; 32(6):1233-40. PubMed ID: 21887553
[TBL] [Abstract][Full Text] [Related]
16. CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer.
Chacko P; Rajan B; Mathew BS; Joseph T; Pillai MR
Breast Cancer; 2004; 11(4):380-8. PubMed ID: 15604994
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians.
Agrawal S; Tripathi G; Prajnya R; Sinha N; Gilmour A; Bush L; Mastana S
Indian J Med Sci; 2009 Aug; 63(8):335-44. PubMed ID: 19770524
[TBL] [Abstract][Full Text] [Related]
18. Role of GSTM1 (Null/Present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: a case control study from South India.
Samson M; Swaminathan R; Rama R; Sridevi V; Nancy KN; Rajkumar T
Asian Pac J Cancer Prev; 2007; 8(2):253-7. PubMed ID: 17696741
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
20. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype.
García-González MA; Quintero E; Bujanda L; Nicolás D; Benito R; Strunk M; Santolaria S; Sopeña F; Badía M; Hijona E; Pérez-Aísa MA; Méndez-Sánchez IM; Thomson C; Carrera P; Piazuelo E; Jiménez P; Espinel J; Campo R; Manzano M; Geijo F; Pellisé M; González-Huix F; Espinós J; Titó L; Zaballa M; Pazo R; Lanas A
Mutagenesis; 2012 Nov; 27(6):771-7. PubMed ID: 22952149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
